Skip to main content
. 2017 Mar 9;17(6):483–489. doi: 10.14744/AnatolJCardiol.2017.7582

Table 1.

Demographic, clinical and laboratory characteristics of the patient and the control groups according to the SYNTAX score

Variables Group 1 (SYNTAX 0-21) (N:25) Group 2 (SYNTAX ≥22) (N:23) Controls (N:15) P
Age, years 58.2±8.12 59.1±5.9 57.6±9.5 0.06
Gender, male % 52.7 53.0 52.0 0.062
BMI 24.2±2.1 23.8±2.0 24.1±1.9 0.1
Number of smokers 16 14 7 0.02
WBC count, 103/mm3 8.1±1.15 8.1±1.25 6.9±1.3 0.690
Hb, gr/L 14.1±0.76 13.33±0.83 14.36±0.82 0.082
Htc 40.1±2.35 38.9±2.35 42.93±2.33 0.69
Plt count, 103/mm3 192±76.2 220±84 228±84.26 0.53
MPV, fL 7.05±1.05 6.55±1.21 7.2±1.3 0.09
Creatinine, mg/dL 0.72±0.14 0.69±0.17 0.69±0.17 0.08
AST, U/L 24±2.15 20.16±3.22 19.69±3.2 0.568
ALT, U/L 28.2±4.1 30.1±5.02 26.89±4.12 0.784
TG, mg/dL 169.12±26.1 156.88±22.75 117.28±22.17 0.058
TC, mg/dL 175.8±19.2 188.67±15.95 145.62±14.75 0.088
LDL, mg/dL 149.1±12.4 153.33±11.83 121.92±12.06 0.96
Glucose, mg/dL 115.3±17.09 144.3±15.96 98.4±8.77 0.223
Diabetics, % 32 56.6 0 0.004
Hypertensives, % 48 43.5 0 0.051
SBP, mm Hg 121.22±10.24 122.32±11.84 113.62±8.23 0.258
HR, beat/min 73.98±12.55 72.98±12.55 72.23±12.43 0.163
EF, % 60 (55,65) 57 (54,65) 65 (52,68) 0.210
MN frequency, /1000 3.8 (1.7,8.2) 6.2 (1.7,24.5) 0.83 (0.7,0.9) 0.001a
NDI 1.43 (1.3,1.7) 1.42 (1.1,1.8) 1.54(1.5,1.6) 0.003b
SYNTAX score 14.2±3.24 33.5±1.45 N/A 0.001
Gensini score 55.66±15.32 69.7±17.26 N/A 0.001
LAD TFC 14.9±2.6 17.9±5.8 N/A 0.001
Cx TFC 12.5±4.2 18.3±4.6 N/A 0.001
RCA TFC 9.4±1.1 12.3±0.9 N/A 0.001

Continuous variables were presented as mean ±standard deviation and median (min-max), while categorical variables were given as percentages. The Kolmogorov-Smirnov test was used to verify the normality of the distribution of continuous variables. Statistical analysis of clinical data between two groups consisted of unpaired t-tests for parametric data and Mann-Whitney U test analysis for nonparametric data, whereas one-way analysis of variance or Kruskal-Wallis tests was used to evaluate comparisons between the 3 groups. Post-hoc analysis was carried out by Bonferroni correction test.

ALT - alanine aminotransferase; AST - aspartate aminotransferase; Cx - circumflex artery; EF - ejection fraction; Hb - hemoglobin; HDL - high density lipoprotein; HR - heart rate; Htc - hematocrit; LAD - left anterior descending artery; LDL - low density lipoprotein; MN - micronucleus; MPV - mean platelet volume; NDI - nuclear division index; Plt - platelet; RCA - right coronary artery; SBP - systolic blood pressure; TC - total cholesterol; TG - triglyceride; TFC - thrombolysis in myocardial infarction frame count; WBC - white blood count

a

Controls and Group 1, P=0.001; Controls and Group 2, P=0.001; Group 1 and Group 2, P=0.001.

b

Controls and Group 1, P=0.008; Controls and Group 2, P=0.001; Group 1 and Group 2, P=0.002.